470 related articles for article (PubMed ID: 24905879)
1. Induced pluripotent stem cells for regenerative medicine.
Hirschi KK; Li S; Roy K
Annu Rev Biomed Eng; 2014 Jul; 16():277-94. PubMed ID: 24905879
[TBL] [Abstract][Full Text] [Related]
2. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
3. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
[TBL] [Abstract][Full Text] [Related]
4. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.
Campbell KA; Terzic A; Nelson TJ
Regen Med; 2015; 10(6):773-83. PubMed ID: 26439809
[TBL] [Abstract][Full Text] [Related]
6. Efficient hepatic differentiation from human iPS cells by gene transfer.
Kawabata K; Inamura M; Mizuguchi H
Methods Mol Biol; 2012; 826():115-24. PubMed ID: 22167644
[TBL] [Abstract][Full Text] [Related]
7. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
[TBL] [Abstract][Full Text] [Related]
8. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
9. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies.
Selvaraj V; Plane JM; Williams AJ; Deng W
Trends Biotechnol; 2010 Apr; 28(4):214-23. PubMed ID: 20149468
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.
Lou X
Stem Cell Rev Rep; 2015 Aug; 11(4):645-51. PubMed ID: 26022504
[TBL] [Abstract][Full Text] [Related]
11. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases.
Chakraborty C; Shah KD; Cao WG; Hsu CH; Wen ZH; Lin CS
Curr Mol Med; 2010 Nov; 10(8):756-62. PubMed ID: 20937020
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-like cells derived from induced pluripotent stem cells.
Roy-Chowdhury N; Wang X; Guha C; Roy-Chowdhury J
Hepatol Int; 2017 Jan; 11(1):54-69. PubMed ID: 27530815
[TBL] [Abstract][Full Text] [Related]
13. [Cartilage regeneration using cell reprogramming technologies].
Tsumaki N
Clin Calcium; 2013 Nov; 23(11):1641-8. PubMed ID: 24162605
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
Nsair A; MacLellan WR
Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511
[TBL] [Abstract][Full Text] [Related]
15. Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
Ye Z; Cheng L
Regen Med; 2010 Jul; 5(4):521-30. PubMed ID: 20632856
[TBL] [Abstract][Full Text] [Related]
16. [Induced pluripotent stem cells: a new paradigm to study human tissues].
Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
18. iPS cell technologies and cartilage regeneration.
Tsumaki N; Okada M; Yamashita A
Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
[TBL] [Abstract][Full Text] [Related]
19. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.
Mack DL; Guan X; Wagoner A; Walker SJ; Childers MK
Am J Phys Med Rehabil; 2014 Nov; 93(11 Suppl 3):S155-68. PubMed ID: 25122102
[TBL] [Abstract][Full Text] [Related]
20. iPS cell technologies: significance and applications to CNS regeneration and disease.
Okano H; Yamanaka S
Mol Brain; 2014 Mar; 7():22. PubMed ID: 24685317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
